Literature DB >> 11934902

c-Src-dependent transcriptional activation of TFII-I.

Venugopalan Cheriyath1, Zana Patrick Desgranges, Ananda L Roy.   

Abstract

TFII-I is a multifunctional transcription factor that is also involved in signal transduction. Here we show that TFII-I undergoes a c-Src-dependent tyrosine phosphorylation on tyrosine residues 248 and 611 and translocates to the nucleus in response to growth factor signaling. Tyrosine-phosphorylated nuclear TFII-I activates a stably integrated c-fos reporter gene. Withdrawal of signal leads to diminution of nuclear TFII-I, suggesting that the signal-dependent translocation is reversible. Antibodies against either TFII-I or c-Src abrogate growth factor-stimulated activation of c-fos. Consistent with the notion that tyrosine phosphorylation of TFII-I is required for its transcriptional activity, phosphorylation-deficient mutants of TFII-I fail to activate the c-fos promoter. These data demonstrate that TFII-I, through a Src-dependent mechanism, reversibly translocates from the cytoplasm to the nucleus, leading to the transcriptional activation of growth-regulated genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934902     DOI: 10.1074/jbc.M202956200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.

Authors:  Yahao Bu; Lingqiu Gao; Irwin H Gelman
Journal:  Int J Cancer       Date:  2011-04-15       Impact factor: 7.396

2.  CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma.

Authors:  J Tang; Y-S Guo; Y Zhang; X-L Yu; L Li; W Huang; Y Li; B Chen; J-L Jiang; Z-N Chen
Journal:  Cell Death Differ       Date:  2012-05-18       Impact factor: 15.828

3.  Inhibition of TFII-I-dependent cell cycle regulation by p53.

Authors:  Zana P Desgranges; Jinwoo Ahn; Maria B Lazebnik; Todd Ashworth; Caleb Lee; Richard C Pestell; Naomi Rosenberg; Carol Prives; Ananda L Roy
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 4.  Role of helix-loop-helix proteins during differentiation of erythroid cells.

Authors:  Archana Anantharaman; I-Ju Lin; Joeva Barrow; Shermi Y Liang; Jude Masannat; John Strouboulis; Suming Huang; Jörg Bungert
Journal:  Mol Cell Biol       Date:  2011-01-31       Impact factor: 4.272

Review 5.  Signal-induced functions of the transcription factor TFII-I.

Authors:  Ananda L Roy
Journal:  Biochim Biophys Acta       Date:  2007-10-11

6.  Williams-Beuren syndrome-associated transcription factor TFII-I regulates osteogenic marker genes.

Authors:  Maria B Lazebnik; Maria Isabel Tussie-Luna; Philip W Hinds; Ananda L Roy
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

7.  Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I.

Authors:  Jaya Rajaiya; Jamee C Nixon; Neil Ayers; Zana P Desgranges; Ananda L Roy; Carol F Webb
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

8.  Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.

Authors:  Jaya Rajaiya; Melissa Hatfield; Jamee C Nixon; David J Rawlings; Carol F Webb
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.

Authors:  Timothy A Hinsley; Pamela Cunliffe; Hannah J Tipney; Andrew Brass; May Tassabehji
Journal:  Protein Sci       Date:  2004-10       Impact factor: 6.725

10.  Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells.

Authors:  Catarina Sacristán; Stefan A Schattgen; Leslie J Berg; Stephen C Bunnell; Ananda L Roy; Yvonne Rosenstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.